Pharmaceuticals. Accelerate Time-to-Market. Increased Competitiveness.

With long and expensive R&D cycles, patent expirations and increasing competition from generics, pharmaceutical companies are going through strategic changes in order to accelerate time-to-market and improve the profitability of new products.

Streamlined manufacturing processes

Within a global and multi-site framework, pharmaceutical manufacturers are always looking for better control and increased visibility of their manufacturing processes. The use of advanced technology and automation can greatly help pharmaceutical manufacturers to:

• Meet continually evolving regulatory requirements such as FDA, cGMP, 21CFR Part 11 and more
• Guarantee safety, quality and traceability of manufactured products
• Streamline processes to improve productivity and reduce costs
• Implement continuous improvement strategies with the view to increased competitiveness

XFP-MES: Robust, pre-validated solutions designed for pharmaceuticals

From product development to clinical batch manufacturing to commercial production, the XFP-MES suite provides modular and flexible solutions that:

• Strengthen regulatory compliance
• Reduce risks and increase visibility
• Reduce cycle time and optimize resource use
• Direct, control and improve manufacturing steps up to batch release

Directed production, real time visibility

Seamlessly integrated with ERPs and any other components of the supply chain, XFP-MES drives and tracks all activities related to the manufacture of pharmaceutical products.

Operational excellence through advanced technologies

The OPM technology includes an advanced workflow engine specifically designed to enhance process quality and performance in total safety.
By providing reliable traceability and total mastery of all pharmaceutical processes, the XFP-MES suite is an essential technology solution for achieving the operational excellence of paperless manufacturing sites.